Company: OMQS
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001813
Chunk: 748

Company: OMNIQ Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9A
Chunk 748
---
 the option period determined by the Board of Directors, which may vary, but will not
exceed ten years from the date of the grant.

For options exercised during the year ended December
31, 2024, the difference between the fair value of the Common Stock issued and the respective exercise price was $622 thousand. As of
December 31, 2024, the intrinsic value for vested stock options was $0.

For
options exercised during the year ended December 31, 2023, the difference between the fair value of the Common Stock issued and the respective
exercise price was $373 thousand. As of December 31, 2023, the intrinsic value for vested stock options was $0.

As of December 31, 2024, the total compensation cost related to nonvested
awards not yet recognized as $142 thousand. As
of December 31, 2023 the total compensation cost related to nonvested awards not yet recognized was $355 thousand. The weighted average
period over which it is expected to be recognized is 2 months.

Stock
Options - The following table summarizes information about stock options granted during the years ended December 31,

 SCHEDULE OF STOCK OPTIONS GRANTED

    2024  
    2023 

    Number
    of Stock  Options  
    Weighted Average
    Exercise Price  
    Number
    of Stock  Options  
    Weighted Average
    Exercise Price 

    Balance, beginning of year 
     1,508,833  
    $4.97  
     2,190,583  
    $5.00 

    Stock options granted 
     -  
     -  
     50,000  
     - 
  
    Stock options expired 
     -  
     -  
     (287,750) 
     - 
  
    Stock options cancelled, forfeited 
     (215,000) 
     -  
     (208,574) 
     - 
  
    Stock options exercised 
     - 
     -  
     (235,426) 
     - 

    Balance, end of year 
     1,293,833  
     4.81  
     1,508,833  
     4.97 

    Exercisable stock options 
     1